Outcomes of Salvage IMRT for Recurrent Head and Neck Cancer
Author Information
Author(s): Gabriela Studer, Klaus W. Graetz, Christoph Glanzmann
Primary Institution: University Hospital Zurich
Hypothesis
The study aims to analyze the outcomes of recurrent head and neck cancer patients treated with salvage intensity modulated radiation therapy (IMRT).
Conclusion
The study found a low salvage rate of only about 50% at two years for patients treated with salvage IMRT.
Supporting Evidence
- 50% of patients were alive with no evidence of disease after two years.
- 41% of patients died from the disease within a mean of 9.8 months after salvage treatment.
- The study calculated numbers needed to treat to avoid one recurrence with postoperative IMRT.
Takeaway
This study looked at patients with recurring throat cancer who got special radiation treatment after surgery, and it showed that only half of them were cancer-free after two years.
Methodology
Retrospective analysis of outcomes following salvage IMRT in patients with recurrent head and neck cancer.
Potential Biases
The small sample size may limit the generalizability of the findings.
Limitations
The study has a small sample size and a short follow-up period.
Participant Demographics
Mean age at diagnosis was 64.3 years, with a male to female ratio of approximately 2:1.
Statistical Information
P-Value
0.03
Statistical Significance
p = 0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website